A Study to Evaluate the Long-term Safety of TAK-771 in Japanese Primary Immunodeficiency Disease (PID) Participants
Condition: Primary Immunodeficiency Diseases (PID) Intervention: Drug: TAK-771 Sponsor: Takeda Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials